🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT07308171 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age ≥ 18 years 2. Tracheostomy and mechanical ventilation 3. Dyspnea ≥3 4. Consent to participate 5. Affiliation to health insurance Exclusion Criteria: 1. Agitation, delirium 2. Continuous use of sedatives 3. Patients under law protection 4. Inmates 5. Patients without health insurance 6. Breastfeeding and pregnancy
💊

What it tests

  • Baseline
  • Installation of high flow humidified air cannula
  • Nasal air puffs
  • propeller fan (FAN)
📍

Where

1 site
Hôpital Pitié Salpêtrière
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy